chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mild rash from first dose, urgent care was not sure if rash was related to vaccine, intense rash from second dose. High fevers 102.4. Intense muscle pain. Pain from second dose injection site spread down arm and up into neck.
On day 2, left shoulder turned red near injection site.  On day 4, redness turned into a small patch of hives on left shoulder (injection site). Today is day 6 and hives are still present.
Arm redness still present after 1/11 dose until present date 1/27.  Area of redness seems to be growing in size.
I experienced red/rash hive like on my left arm, less on my right, and redness and slight itching of my thighs. The itching feeling of thighs and arms went away after hour; but still see redness (less on thighs). Slight itching at injection site. Dry throat made me paranoid I would have an anaphylactic reaction but I haven't and this is my fourth shot and I have never experienced that. before. This is the first time I have had itching/rash like symptoms after a COVID test - previously just muscle ache, lymph nodes swelling for 24 hours, and extreme fatigue that lasted a day.
Chest discomfort and tightness with minor pain no radiating to other locations of body. Elevated blood pressure. Hospital medical staff contacted and consulted recommended medical intervention and given pros and cons of actions. EMT/medical response recommendation medical intervention to which patient refused. Patient getting aggravated and refusing hospital/emergency transport  No transport or medication accepted at this time.
pt recv vax 18SEP97 530PM & mom noticed accidental overdosage, not the med personnel giving the vax;MD instructed the child mom to give child APAP @ bedtime;pt exp leg weakness;woke next morning w/no unusual sx & went to school;
Fever to 103 on 6/16/11. Positive vesicular to ulcerative to crusting rash on all 4 extremities (started 6/15/11). Evaluated by me on 6/16/11. Patient admitted to hospital 6/16/11 started on IVF positive oral acyclovir 80mg/hr/day.
high blood pressure/her blood pressure is 165/114; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine; Lot number: EK9231), via an unspecified route of administration in the left arm on 12Jan2021 at 09:30 as a single dose for COVID-19 immunization. The patient had no relevant medical history and had no concomitant medications. History of all previous immunizations with Pfizer Vaccine considered as suspect was reported as none (this was the first dose received), did not have additional vaccines administered on the same date as the Pfizer vaccine, and did not have any prior vaccinations within four weeks. The patient mentioned that after getting the first shot of the COVID-19 vaccine, her blood pressure was 165/114 in the morning of 14Jan2021. She has never had high blood pressure and wanted to know if this was normal after getting the vaccine. The last three days she has been taking her blood pressure and it had been high. On 18Jan2021, the patient's blood pressure was 165/108. Her previous blood pressure readings have been in the 160's over 108-114. Reiterated that she has never had high blood pressure before. She was scheduled to get second dose on 02Feb2021. The event did not require a visit to the Emergency Room or Physician's Office and she has not gone yet to the hospital. Everyone wanted her to, but she did not want to go. She stated she did not like hospitals. Outcome of the event was not recovered.
Patient received the Janssen Covid-19 vaccine and after a couple minutes in observation she developed pruritis to both arms and neck. Was given po diphenhydramine 25mg and patient monitored for additional 15 minutes. Pruritis got better after diphenhydramine and patient went home.  Was counseled to RTC if experiencing any SOB/hives/rash etc.
Patient tested positive and was admitted to hospital on 01/17/2022.  Symptoms: Feverish, Chills, Muscle aches, cough, and diarrhea,  He was treated with IV remdesavir daily for 5 days beginning on 01/22/2022.  No underlying health conditions charted in system or by medical staff.
Patient was nervous about receiving this vaccine (has fainted in the past with previous vaccinations). Within 5 minutes of receiving the vaccine, she became pale and quiet, and complained of ringing in the ears. The patient was laid down flat and given an ice pack and some water, and felt back to normal within 20 minutes.
Pt immediately had swelling (looked like a bubble formed at the site).  Treated with ice pack, pt was okay in 20 minutes.  No reaction several hours later.
SUFFERED BECAUSE OF THE VACCINE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031 expiry: UNKNOWN) dose, start therapy date were not reported for covid-19 prophylaxis. No concomitant medications were reported. On an unspecified date, the patient experienced suffered because of the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suffered because of the vaccine was not reported. This report was non-serious.
COVID arm injection site has rash/swollen/hot to touch started today (april 8) but received shot on March 30
Painful right arm at site of injection w/flu-like symptoms. Went to ER 09/20/14 and discharged same night w/arm sling. Returned to ER 09/22/14 due to increased arm pain and swelling. She was admitted and treated for cellulitis w/IV antibiotics. She was discharged 09/25/14.
48 hours after injection, patient developed an approximate 4 inch by 3 inch large, hard, hot, red, painful circular area at injection site on right hip/thigh with 1-2 small blisters. Mother applied cold compress periodically for 48 hours until site improved. Patient also, 4 days after injection, broke out in a red rash on back, hips and buttocks that lasted approximately 24 hours.
pt recv vax SEP95 & APR97 pt exp less than 50 lesions;
Pt states: " I have a spreading scab where i got the pneumonia vaccine. Its about 2.5cm by1. it does not hurt..."   pt. sent picture to PCP who states: " it looks like you had a superficial inflammatory reaction, and secondary escahr (scab). since the area is not an angry red, i don't think this is currently infected."
1st day just sore arm. 2nd day just felt off, 3rd day mild headache chills, 4th day sever headache, vomitting, nausea, stiff neck and shoulders.
Booster; Allergic reaction; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose3 (booster) single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1), for COVID-19 Immunisation; Covid-19 vaccine (Dose 2), for COVID-19 Immunisation. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Booster"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Allergic reaction".  Additional information: Consumer stated, "I think I am having 'non-severe' allergic reaction (Further clarification unknown) to the Pfizer booster shot." Consumer stated, "What can you do if I am having an allergic reaction which I think I am, what I need to do that's all you need to tell me." When paraphrased the above concern, consumer stated, "What I am going to do is, I am going to call where I live at, I am going to a call a hospital because I need to know what to do and you know I barely get you, I know you do not know what I can do at this present time, I need to talk to someone to tell me right away. I might have to call a hospital or something." In response to further probing, consumer stated, "No, I don't think I can do it right now. I don't think so, I can't quite understand you I cannot answer clearly. I am just going to call a hospital." QR comment: Reporter type was not available over the call as the consumer was unwilling to answer further questions; hence reporter type was captured as consumer or non-healthcare professional by default.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Nurse administered Polio vaccine that was expired on 11/14/19, NO symptoms noted
This serious spontaneous case, initially received from a pharmacist on 10-Oct-2018, concerning a female patient of unspecified age. On an unspecified date (reported as few years ago), the patient was administered influenza vaccine [dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported]. On an unspecified date, after vaccination, the patient experienced a near anaphylaxis reaction. At the time of this report, the outcome of the event was not reported.
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 11-Jun-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  Date of refrigeration was 07-MAY-2021.
Patient very apprehensive re flu vaccine. Told to wait 15 min since it was 1st time to get shot. LPN noticed pt. starting to slump in chair. RN came to aid - put head of pt between knees. Fainted 8 seconds or less then was to verbalize & oriented - diaphoretic AP 84. 911 called pt transported to hospital.
Rash on arm, then bad headaches, real bad headaches, When driving this last Monday. I would pass out at the wheel. At least 4 times I jumped the median.  Got lost in a nearby neighborhood. Once I figured out what was going on I went straight home.
Mild muscle aches and sore throat x 6 hours then temp>101 for four hours the general body ache 9/17 all day and laryngitis with post nasal drip 9/18- Zithromax given to prevent secondary upper respiratory symptoms.
Myalgias, fever to 101degrees, intense lower abdominal cramping with non-bloody diarrhea for 2 days.
Patient had pain and inflammation at the injection site. Shortness of breath and chest pain experienced as well. Treatment was observational.
Patient fainted for a few seconds after receiving vaccine. She woke up immediately and took a few minutes to feel normal.
Patient experienced tingling/muscle spasms in right arm 5 minutes post injection and in left arm 8 minutes post injection. At 10 minutes she claimed she had a "funny Feeling in chest" and she was given Benadryl. 911 was called and they observed her for 10 minutes before patient signed a release and left the building.
Local reaction in both legs with redness & swelling. Warmth & itching also noted.
Information regarding PREVNAR 13 was received from a pediatrician regarding a 30-month-old male patient who experienced severe local reaction - pain, swelling, redness. The patient received the first dose in Jun-2010. The patient experienced severe local reaction - pain, swelling, redness on 11-Jun-2010. All events resolved on an unknown date. No additional information was available at the time of this report.
Fever (up to 104) for 24 hours, uncontrollable crying/screaming/irritability off and on for 1 week
Vaccines administered 1/18/06. Febrile seizure 1/23/06. Also had otitis.
Inc T 104 on 8JUL91; Inc T 102 on 9JUL91; Took to clinic.
immunization was given within 12 hours of withdrawal/was drawn up and not given from vaccine clinic the night before; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (immunization was given within 12 hours of withdrawal/was drawn up and not given from vaccine clinic the night before) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 027B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021 at 7:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021 at 7:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (immunization was given within 12 hours of withdrawal/was drawn up and not given from vaccine clinic the night before). At the time of the report, EXPIRED PRODUCT ADMINISTERED (immunization was given within 12 hours of withdrawal/was drawn up and not given from vaccine clinic the night before) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter   Reporter did not allow further contact
This spontaneous report was received from a registered nurse and refers to an 8-week-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 20-DEC-2018, the patient was vaccinated with improperly stored dose of LIQUID PEDVAXHIB, lot # R014261, expiration date 25-MAR-2021 or lot # R005118, expiration date 28-NOV-2020 (dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/ 0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (it was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient). Sender's Comments: US-009507513-1901USA000071.
Pt. came to office 11-5-12 and received vaccines. Pt. came back to office 11-8-12 with temp of 105 rectal. Pt. was hospitalized 11-8-12 and discharged 11-11-12. Fever thought to be from viral process.
Patient reported headache and nausea. Both have gone away. This is being reported because patient received second dose of Moderna COVID Vaccine 14 days after first dose.
Rash on chest and around injection site. Pounding headache lasted 2 days. Emesis all Friday night and Saturday and finally afebrile yesterday afternoon. lasting 3 days.
2nd dose not received yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (1st dose received in September 2021).   On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: 2nd dose not received yet). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 13-NOV-2023 The pharmacist reported on November 13th 2023 that patient received the first dose of Twinrix on September 2021 and the second dose was not administered yet. The reporter did not consent to follow up. The vaccine administration facility is the same as primary reporter. Till the time of reporting, the patient did not receive 2nd dose of Twinrix, which led to incomplete course of vaccination
Headache. I took ibuprofen for the past 20 hours but headache and sore arms did not go away completely. Now I have just taken excedrin.
No desire to eat; The next day "I" did not feel the pressure "I" have felt due to COPD. The heavy tight pressure on "my" chest from COPD was gone.; Lack of energy; "I" feel spacey, sometimes dizzy.; "I" feel spacey, sometimes dizzy.; "I" will say "I" have been so very very tired since shot and now going on day 3; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 04:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The medical history included penicillin allergy, sulfa drug allergy, chronic obstructive pulmonary disease (COPD), asthma and heavy tight chest pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included fluticasone propionate/salmeterol xinafoate (ADVAIR), tiotropium bromide monohydrate (SPIRIVA), atorvastatin (MANUFACTURER UNKNOWN) and multivitamin(unspecified), all from unknown dates for unknown indications and unknown if ongoing. The patient previously took minocycline hydrochloride (MINOCIN), cefoxitin (MANUFACTURER UNKNOWN) cefaclor (CECLOR) from an unknown date and experienced allergy. On 06Mar2021, since the shot, the patient had been so very very tired and was going on day 3 at the time of report. The patient had reported that first there was a good event on 07Mar2021 at 08:00, the next day after vaccination, the patient did not feel the pressure she had felt due to chronic obstructive pulmonary disease (COPD). The heavy tight pressure on her chest from COPD was gone. It was reported that the patient had COPD for a long time and had forgotten how it felt not to have had the pressure on her chest. She reported that it was amazing and it was a miracle. On 07Mar2021, the patient felt spacey, sometimes dizzy, no desire to eat and lack of energy. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event did not feel the pressure that was felt due to COPD was unknown, while the clinical outcome of very very tired, felt spacey, sometimes dizzy, no desire to eat and lack of energy were not recovered at the time of this report.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Chills, elevated heart rate, racing thoughts, shortness of breath, sleeplessness; I remained awake until around 8AM the following morning.
Four days after Pediatrix in Left deltoid-arm are swollen, red and macular rash.
Hard bump on arm where vax given-arm feels warm & area is tender & reddened; 16JUN92 tc to mom bump is gone; heat was applied; no longer feels warm;
PATIENTS LEFT ARM BECAME INFLAMED AND STARTED TO SWELL THE MORNING AFTER THE VACCINE.  PATINET STATES SWELLING INCREASED OVER THE NEXT FEW DAYS.  SHE SAW DR ON 04/18/23.  DOCTOR THINKS THE ARM IS INFECTED OR POSSIBLE CELLUCITIS.  STARTED ANTIBIOTIC TREATMENT. PATIENT STATES THAT ARM IS SLOWLY GETTING BETTER.
6/8/01 cold symptoms. Fever 105.1F irritability. diarrhea. blood culture positive for Strep pneumoniae (pain sensitive) Pt had received 3 doses of Prevnar. Received ceftniaxone times 1 then po Augmentin.
Patient was admitted and treated for severe PE and DVT, as well as hypoxia and paroxysmal SVT. Pt was discharged to inpatient rehab when stable
The morning after she got her shot, she experienced sharp pain in thumb.  It has been 6 days since she got the shot and she is still experiencing the sharp pain.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported but it could be 50 years or 51 years. The patient's wife reported that her husband received the 1st dose of SHINGRIX last year and approximately 1 year later, received the 2nd dose. The patient experienced soreness at the injection site after first dose which subsided after 2 to 3 days. For tolerability of the second dose of SHINGRIX, refer case US2019023105.
Significant swelling after 24 hours in my undereye and smile lines on my face. The swelling started to become significant just at the 24 hour mark after receiving my 2nd dose of Moderna. I have had cosmetic fillers in my under eye and smile lines. That said, my last treatment for cosmetic fillers was in December 2020, over 4 months prior to receiving this vaccine.
3 days after second dose: Itchy hives on legs and torso, and arms to a lesser extent. Persisted for 2.5 days. After hives subsided, achy and mild chills. Some post-Guillain-Barre residual sensations in legs recurred as well and still continuing, 9 days after the second dose.
Patient presented from skilled nursing facility on 11/23/2021 with unresponsiveness. He was diagnosed with COVID-19 infection on 11/18/2021. Patient was intubated and admitted to intensive care unit. Patient remained in critical condition during admission and was changed to comfort measures only. He expired on 11/30/2021.
Red rash developed all over her body, minor swelling in the eyes and tongue, listlessness and lethargy.  Patient was aken to the emergency room where she was given Benadryl and observed for several hours.